Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.8 TWD -0.12%
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maxigen Biotech Inc
Operating Income Peer Comparison

Comparables:
G
1707
1731
4137

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
Operating Income
NT$124.9m
CAGR 3-Years
16%
CAGR 5-Years
21%
CAGR 10-Years
N/A
G
Grape King Bio Ltd
TWSE:1707
Operating Income
NT$2.4B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
5%
Maywufa Co Ltd
TWSE:1731
Operating Income
NT$204.4m
CAGR 3-Years
1%
CAGR 5-Years
7%
CAGR 10-Years
10%
Chlitina Holding Ltd
TWSE:4137
Operating Income
NT$1B
CAGR 3-Years
-12%
CAGR 5-Years
-10%
CAGR 10-Years
2%

See Also

What is Maxigen Biotech Inc's Operating Income?
Operating Income
124.9m TWD

Based on the financial report for Jun 30, 2024, Maxigen Biotech Inc's Operating Income amounts to 124.9m TWD.

What is Maxigen Biotech Inc's Operating Income growth rate?
Operating Income CAGR 5Y
21%

Over the last year, the Operating Income growth was -30%. The average annual Operating Income growth rates for Maxigen Biotech Inc have been 16% over the past three years , 21% over the past five years .

Back to Top